Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
12-16 September, 2025
SCI Medicinal Chemistr...SCI Medicinal Chemistry
Not Confirmed
Not Confirmed
14-17 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
12-16 September, 2025
SCI Medicinal Chemistr...SCI Medicinal Chemistry
Industry Trade Show
Not Confirmed
14-17 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
03 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-03/aldeyra-therapeutics-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference
28 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-28/aldeyra-therapeutics-receives-orphan-designation-from-the-european-medicines-agency-for-adx-2191-for
19 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250819317013/en/Aldeyra-Therapeutics-Receives-Fast-Track-Designation-for-ADX2191-for-the-Treatment-of-Retinitis-Pigmentosa
06 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250806352225/en/Aldeyra-Therapeutics-to-Participate-in-the-H.C.-Wainwright-5th-Annual-Ophthalmology-Virtual-Conference
17 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250717410973/en/Aldeyra-Therapeutics-Announces-FDA-Acceptance-for-Review-of-Reproxalap-New-Drug-Application-for-the-Treatment-of-Dry-Eye-Disease
26 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250626651175/en/Aldeyra-Therapeutics-Receives-Special-Protocol-Assessment-Agreement-Letter-from-the-U.S.-Food-and-Drug-Administration-for-ADX-2191-for-the-Treatment-of-Primary-Vitreoretinal-Lymphoma
ABOUT THIS PAGE